CytoMed Therapeutics Ltd - Ordinary Shares (GDTC)

CUSIP: Y1R80M106

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class
Equity / Ordinary Shares
Total 13F shares
0
Total 13F value
$0
Holder snapshot 5 signals
Share change
-13
SEC-reported price per share
$1.09
Number of holders
0
Value change
-$28
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
11,735,810

Security key

Y1R80M106

Report period

Q2 2024

Institutions

0

Top holders

0

GDTC full security history Newer quarter: Q3 2024 Previous quarter: Q1 2024 CytoMed Therapeutics Ltd SEC filings CytoMed Therapeutics Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

There are no holders of GDTC - CytoMed Therapeutics Ltd - Ordinary Shares as of Q2 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .